ClinicalTrials.Veeva

Menu

Influence of Synacthen Infusion on the Results of Adrenal Venous Sampling in Patient With Primary Aldosteronism (ISIRA)

C

Charles University, Czech Republic

Status and phase

Unknown
Phase 4

Conditions

Primary Aldosteronism

Treatments

Drug: Synacthen infusion during adrenal venous sampling

Study type

Interventional

Funder types

Other

Identifiers

NCT02127840
PAAVS1143

Details and patient eligibility

About

The project is aimed to determine the value of synacthen infusion on the results of adrenal venous sampling in patients examined for primary aldosteronism

Full description

We aim to compare the results of adrenal venous sampling performed without and during synacthen infusion.

Enrollment

40 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria: Confirmed primary aldosteronism

Exclusion Criteria: Inability to undergo unilateral adrenalectomy

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

40 participants in 2 patient groups

Synacthen
Experimental group
Description:
Synacthen infusion during adrenal venous sampling
Treatment:
Drug: Synacthen infusion during adrenal venous sampling
Without Synacthen
No Intervention group
Description:
Adrenal venous sampling without Synacthen

Trial contacts and locations

1

Loading...

Central trial contact

Miroslav Solar, MD; Jiri Ceral, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems